Human Genome Epidemiology Literature Finder
|
Records 1 - 6 (of 6 Records) |
| Query Trace: Adenoma and CYP2C9[original query] |
|---|
| CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk. Cancer research 2001 May 61 (9): 3566-9. Bigler J, Whitton J, Lampe J W, Fosdick L, Bostick R M, Potter J |
| A prospective study of genetic polymorphisms in the cytochrome P-450 2C9 enzyme and the risk for distal colorectal adenoma. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2004 Aug 2 (8): 704-12. Chan Andrew T, Tranah Gregory J, Giovannucci Edward L, Hunter David J, Fuchs Charles |
| Genetic variants of UGT1A6 influence risk of colorectal adenoma recurrence. Clinical cancer research : an official journal of the American Association for Cancer Research 2006 Nov 12 (21): 6585-9. Hubner Richard A, Muir Kenneth R, Liu Jo-Fen, Logan Richard F A, Grainge Matthew, Armitage Nicholas, Shepherd Vic, Popat Sanjay, Houlston Richard S, |
| Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma. Gastroenterology 2009 Jun 136 (7): 2127-2136.e1. Chan Andrew T, Zauber Ann G, Hsu Meier, Breazna Aurora, Hunter David J, Rosenstein Rebecca B, Eagle Craig J, Hawk Ernest T, Bertagnolli Monica |
| CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment. Cancer causes & control : CCC 2012 Oct . Barry EL, Poole EM, Baron JA, Makar KW, Mott LA, Sandler RS, Ahnen DJ, Bresalier RS, McKeown-Eyssen GE, Ulrich CM |
| Novel Methods of Risk Stratifying Patients for Metachronous, Pre-Malignant Colorectal Polyps: A Systematic Review. Critical reviews in oncology/hematology 2021 7 164 103421. Johnstone Mark S, Lynch Gerard, Park James, McSorley Stephen, Edwards Joan |
- Page last reviewed:Feb 1, 2024
- Content source: